Mesothelioma is a particularly challenging form of cancer to treat due to its aggressive nature and the difficulty of detecting it early. Symptoms may not appear until decades after asbestos exposure; even then, they may be mistaken for other less serious conditions. As a result, mesothelioma is often diagnosed at an advanced stage, which makes it harder to treat effectively.
However, cancer research and treatment advances offer new hope for mesothelioma patients.
There have been several developments around treatment options for cancer in recent years.
Immunotherapy is an innovative approach to cancer treatment that seeks to harness the immune system’s power to fight cancer. This approach works by stimulating or enhancing the body’s natural immune response to recognize and attack cancer cells, which can lead to more effective and long-lasting treatment outcomes.
One of the most promising forms of immunotherapy is checkpoint inhibitors, which block the signals cancer cells use to evade detection by the immune system. These drugs essentially “take the brakes off” the immune system, allowing it to better recognize and attack cancer cells. Checkpoint inhibitors have shown great success in treating other types of cancer, such as melanoma and lung cancer, and researchers are now investigating their potential for mesothelioma.
Another form of immunotherapy is adoptive cell transfer, which involves removing immune cells from a patient’s body, genetically modifying them to better recognize and attack cancer cells, and then infusing them back into the patient’s body. This approach has shown promise in treating certain types of blood cancers, and researchers are now exploring its potential for mesothelioma.
Other forms of immunotherapy include vaccines that stimulate the immune system to recognize and attack cancer cells and cytokine therapy, which involves using proteins called cytokines to boost the immune response to cancer.
While immunotherapy is still a relatively new approach to cancer treatment, it has already shown great promise in treating various cancer types. Researchers are optimistic that immunotherapy could provide a more effective and less toxic alternative to traditional cancer treatments, such as chemotherapy and radiation therapy. As immunotherapy research advances, mesothelioma patients and people with other cancers may have new hope for improved treatment outcomes and a better quality of life.
Targeted therapy is a form of cancer treatment that uses drugs to target specific molecules or proteins involved in the growth and spread of cancer cells. Unlike traditional chemotherapy, which can affect both healthy and cancerous cells, targeted therapy aims to selectively inhibit the activity of cancer cells while minimizing damage to healthy tissues.
In the case of mesothelioma, researchers are identifying specific genetic mutations and proteins driving the growth and spread of the cancer cells. By identifying these targets, researchers can develop drugs that can selectively inhibit them, potentially leading to more effective treatment outcomes.
For example, one target identified in mesothelioma is the protein mesothelin, which is overexpressed in many mesothelioma tumors. Researchers are now developing drugs targeting mesothelin, such as antibody-drug conjugates and chimeric antigen receptor (CAR) T-cell therapy.
Other targets being studied in mesothelioma include the epidermal growth factor receptor (EGFR), which is involved in cell growth and survival, and the vascular endothelial growth factor (VEGF), which promotes the growth of new blood vessels that supply nutrients and oxygen to tumors. Drugs that target these proteins are already in use for other types of cancer and are now being investigated for their potential in mesothelioma.
Overall, targeted therapy offers the potential for more effective and less toxic treatment options for mesothelioma patients. As researchers continue to identify new targets and develop new drugs, targeted therapy may become an increasingly important part of the standard of care for mesothelioma and other types of cancer.
Combination therapy is a promising area of cancer treatment research involving combining multiple treatment modalities to achieve better outcomes. This approach recognizes that cancer is a complex disease that may require a multi-faceted treatment approach to effectively target and eliminate cancer cells.
One example of combination therapy in mesothelioma is chemotherapy and immunotherapy. While chemotherapy can effectively kill cancer cells, it also has toxic effects on healthy cells and can weaken the immune system. Conversely, immunotherapy boosts the immune system to better recognize and attack cancer cells. By combining chemotherapy and immunotherapy, researchers hope to achieve a more powerful and targeted treatment approach that can kill cancer cells while minimizing damage to healthy tissues.
Another example of combination therapy in mesothelioma is surgery and radiation therapy. Surgery can be effective at removing tumors, but it may not be able to eliminate all cancer cells. Radiation therapy can kill any remaining cancer cells after surgery, reducing the risk of recurrence and improving treatment outcomes.
In addition to these combinations, researchers are also exploring the use of targeted therapy in combination with other treatment modalities, such as chemotherapy or immunotherapy. Targeting specific genetic mutations or proteins driving the growth and spread of cancer cells can work in conjunction with other treatments to provide a more effective and personalized approach to cancer treatment.
While combination therapy is still a relatively new area of cancer research, it offers the potential for more effective and targeted treatment approaches for mesothelioma and other types of cancer. As research advances, combination therapy may become an increasingly important part of the standard of care for mesothelioma patients, leading to improved treatment outcomes and a better quality of life.
Clinical trials are research studies that evaluate the safety and effectiveness of new treatments for cancer, including mesothelioma. These trials are essential for advancing our understanding of the disease and developing new treatments to improve patient outcomes.
Several ongoing clinical trials for mesothelioma are testing a range of treatment approaches, including immunotherapy, targeted therapy, and combination therapy. Some of these trials are designed to evaluate the effectiveness of new drugs, while others are focused on improving the effectiveness of existing treatments.
One example of a clinical trial for mesothelioma is a study of an immunotherapy drug called pembrolizumab. This drug works by blocking a protein called PD-1, which cancer cells use to evade detection by the immune system. The trial tests pembrolizumab in combination with chemotherapy to see if the combination is more effective than chemotherapy alone.
Another clinical trial tests the effectiveness of a drug called selinexor in combination with chemotherapy for mesothelioma. Selinexor is a targeted therapy that works by inhibiting the function of proteins involved in the growth and survival of cancer cells.
In addition to these trials, there are also trials investigating the use of surgery, radiation therapy, and other forms of therapy for mesothelioma. These trials are often designed to evaluate the safety and effectiveness of new treatments and identify potential side effects and complications.
Patients with mesothelioma who are interested in participating in clinical trials should talk to their healthcare provider or seek out a specialized mesothelioma treatment center. These centers can provide information about ongoing clinical trials and help patients determine if they are eligible to participate. While clinical trials are not appropriate for all patients, they can offer the opportunity to receive cutting-edge treatments and potentially improve treatment outcomes.
As well as developing and improving different treatment types, scientists are also looking into how technologies may help with cancer treatment.
Artificial intelligence (AI) refers to the development of computer systems that can perform tasks that typically require human intelligence, such as learning, problem-solving, and decision-making. AI is expected to revolutionize how doctors diagnose and treat the disease in cancer treatment.
AI technologies, such as machine learning algorithms, can analyze vast amounts of data from various sources, including medical records, imaging scans, and genetic tests, to identify patterns and insights that may not be apparent to human doctors. For example, AI can help doctors identify cancerous tumors early by analyzing medical images and detecting subtle changes in the tissue.
AI can also assist in developing personalized treatment plans for patients based on their genetic profile and medical history. By analyzing large datasets of patient information, AI algorithms can identify which treatments are likely to be most effective for specific patients, reducing the need for trial-and-error approaches that can lead to unnecessary side effects and prolonged treatments.
Furthermore, AI can help doctors monitor patients during and after treatment, detecting potential complications and providing real-time feedback to adjust the treatment plan accordingly. This can improve patient outcomes and reduce the risk of relapse.
AI in cancer treatment may significantly improve the accuracy and efficiency of diagnosis and treatment, ultimately leading to better patient outcomes and a more effective fight against cancer.
Doctors are using robotics in the treatment of cancer in several ways. Here are some examples:
- Robotic surgery: Surgeons can use robots to perform minimally invasive surgeries to remove cancerous tumors. Robotic surgery allows for greater precision, accuracy, and control during the procedure, which can help to reduce the risk of complications and improve patient outcomes.
- Radiation therapy: Robots can deliver radiation therapy to cancer patients. This allows for highly precise tumor targeting while minimizing radiation exposure to healthy tissue.
- Diagnosis: Robots can be used to perform biopsies and other diagnostic procedures. This can help to identify cancerous cells at an early stage, which can lead to more effective treatment.
- Drug delivery: Researchers are developing robots to deliver chemotherapy drugs directly to tumors while minimizing exposure to healthy tissue. This approach can help to reduce side effects and improve the effectiveness of the treatment.
The use of robotics in cancer treatment is still in its early stages, but it has the potential to revolutionize how we diagnose and treat cancer.
Telehealth, or the use of technology to provide healthcare services remotely, is becoming increasingly popular in the field of cancer treatment. Here are some ways in which telehealth is expected to play a role in the future of cancer care:
- Remote monitoring: Telehealth technologies can remotely monitor cancer patients, allowing doctors to keep track of their symptoms, medication adherence, and overall health status. This can help doctors to identify potential issues early on and intervene before they become more serious.
- Virtual consultations: Telehealth can also be used to conduct virtual consultations between patients and doctors, allowing patients to receive expert advice and guidance without traveling to a clinic or hospital. This can be particularly helpful for patients who live in remote areas or who have difficulty traveling.
- Support groups: Telehealth can also facilitate virtual support groups for cancer patients and their families. This can provide a sense of community and support, which can be especially important for patients feeling isolated or alone.
- Access to clinical trials: Telehealth can also make it easier for cancer patients to participate in clinical trials by allowing them to receive treatment and be monitored remotely. This can help expand access to new and innovative treatments, improving patient outcomes.
Telehealth is expected to play an increasingly important role in the future of cancer care by improving access to care, increasing patient engagement and support, and facilitating the development of new treatments.
Read on for the answers to some commonly asked questions.
Why is there no cure for cancer?
Cancer is a complex disease that can arise from various causes, including genetic mutations, environmental factors, and lifestyle choices. The fact that there are many different types of cancer, each with its own unique characteristics and challenges, makes it difficult to find a single cure that works for all cases.
In addition, cancer cells can be highly adaptive and evolve over time, developing resistance to traditional cancer treatments such as chemotherapy and radiation therapy. Even when a treatment initially appears effective, it may eventually stop working, and new treatment strategies must be developed.
Despite these challenges, cancer research has made significant progress, and many new treatments are being developed. While a complete cure for cancer may not be achievable, there is hope that continued research will lead to better treatments, improved quality of life for cancer patients, and, ultimately, the prevention of many types of cancer.
The future of cancer treatment is bright, with many new and exciting technologies and therapies on the horizon. While there is still much work to be done, researchers and healthcare professionals are working tirelessly to improve the lives of cancer patients and their families.
- Beck, A., et al. (2017). Strategies and challenges for the next generation of antibody–drug conjugates. https://www.nature.com/articles/nrd.2016.268
- Cancer vaccines and their side effects. (2020). https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/immunotherapy/cancer-vaccines.html
- Chemotherapy. (n.d.). https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/chemotherapy.html
- Chia, P. L., et al. (2019). Epidermal growth factor receptor (EGFR)-targeted therapies in mesothelioma. https://pubmed.ncbi.nlm.nih.gov/30916586/
- Clinical trials. (n.d.). https://www.cancer.org/treatment/treatments-and-side-effects/clinical-trials.html
- Clinical trials using selinexor. (n.d.). https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/selinexor?redirect=true
- Duffy, A. M., et al. (2013). Vascular endothelial growth factor (VEGF) and its role in non-endothelial cells: autocrine signaling by VEGF. https://www.ncbi.nlm.nih.gov/books/NBK6482/
- Esfahani, K., et al. (2020). A review of cancer immunotherapy: from the past to the present, to the future. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194005/
- Faust, J. R., et al. (2022). Mesothelin: an immunotherapeutic target beyond solid tumors. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946840/
- How immunotherapy is used to treat cancer. (2019). https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/immunotherapy/what-is-immunotherapy.html
- Image-guided robotic interventions. (2016). https://www.nibib.nih.gov/science-education/science-topics/image-guided-robotic-interventions
- Immune checkpoint inhibitors. (2022). https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors
- Immunotherapy: impacting all cancers. (n.d.). https://www.cancerresearch.org/immunotherapy-by-cancer-type
- Immunotherapy to treat cancer. (2019). https://www.cancer.gov/about-cancer/treatment/types/immunotherapy
- Jaber, N. (2022). Can artificial intelligence help see cancer in new, and better, ways? https://www.cancer.gov/news-events/cancer-currents-blog/2022/artificial-intelligence-cancer-imaging
- Mokhtari, R. B., et al. (2017). Combination therapy in combating cancer. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514969/
- Pembrolizumab immunotherapy versus standard chemotherapy for advanced pre-treated malignant pleural mesothelioma (PROMISE-meso)
- Surgery to treat cancer. (2015). https://www.cancer.gov/about-cancer/treatment/types/surgery
- Targeted therapy to treat cancer. (2022). https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies
- T-cell transfer therapy. (2022). https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy
- The tech revolutionizing cancer research and care. (n.d.). https://www.cancer.gov/news-events/nca50/stories/technologies-and-innovations
- Wang, L. (2022). Telehealth-based cancer care surged during COVID. Will it continue? https://www.cancer.gov/news-events/cancer-currents-blog/2022/pandemic-telehealth-surge-cancer-care